Moreover, miR-590-3p inhibits Golgi phosphoprotein 3 (GOLPH3), a protein associated with a poor prognosis and chemoresistance in BC patients [90], suggesting that miR-590-3p can regulate BC progression through the regulation of GOLPH3. Here, GOLPH3 is linked to breast cancer.